97% of drug candidates in oncology fail in clinical trials. HCS Pharma has developed human 3D cellular model including the matricial microenvironment, in order to better select drug candidates. This model is available for High Content Screening as a service on our Robotic Platform.
BIOMIMESYS® Oncology allows the long-term culture of colon cancer cells and thus chronic treatment with repeated doses, more relevant in the field of anticancer therapy assessment.
For a relevant assessment of your molecules
We incubate your molecules of interest on colon cancer cells in 3D in BIOMIMESYS® Oncology, to assess their therapeutic effect by fluorescence microscopy and automatized image analysis.